BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majidinia M, Mirza-Aghazadeh-Attari M, Rahimi M, Mihanfar A, Karimian A, Safa A, Yousefi B. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. IUBMB Life 2020;72:855-71. [PMID: 31913572 DOI: 10.1002/iub.2215] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Pawar CS, Rajendra Prasad N, Yadav P, Muthu Vijayan Enoch IV, Manikantan V, Dey B, Baruah P. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. Int J Pharm 2023;635:122763. [PMID: 36822336 DOI: 10.1016/j.ijpharm.2023.122763] [Reference Citation Analysis]
2 Petrikaite V, D'Avanzo N, Celia C, Fresta M. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models. Drug Resist Updat 2023;68:100956. [PMID: 36958083 DOI: 10.1016/j.drup.2023.100956] [Reference Citation Analysis]
3 Wang C, Danli Ma, Yu H, Zhuo Z, Ye Z. N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. Heliyon 2023;9:e14001. [PMID: 36915498 DOI: 10.1016/j.heliyon.2023.e14001] [Reference Citation Analysis]
4 Chopra H, Verma R, Kaushik S, Parashar J, Madan K, Bano A, Bhardwaj R, Pandey P, Kumari B, Purohit D, Kumar M, Bhatia S, Rahman MH, Mittal V, Singh I, Kaushik D. Cyclodextrin-Based Arsenal for Anti-Cancer Treatments. Crit Rev Ther Drug Carrier Syst 2023;40:1-41. [PMID: 36734912 DOI: 10.1615/CritRevTherDrugCarrierSyst.2022038398] [Reference Citation Analysis]
5 Nejabat M, Samie A, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM. An Overview on Gold Nanorods as Versatile Nanoparticles in Cancer Therapy. J Control Release 2023;354:221-42. [PMID: 36621644 DOI: 10.1016/j.jconrel.2023.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahmed S, Ahmed MZ, Rafique S, Almasoudi SE, Shah M, Jalil NAC, Ojha SC. Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms. Biomed Res Int 2023;2023:5250040. [PMID: 36726844 DOI: 10.1155/2023/5250040] [Reference Citation Analysis]
7 Albuquerque T, Neves AR, Faria R, Quintela T, Costa D. Chronobiology and Nanotechnology for Personalized Cancer Therapy. Cancer Nanotechnology 2023. [DOI: 10.1007/978-3-031-17831-3_7] [Reference Citation Analysis]
8 Zhao Z, Saiding Q, Cai Z, Cai M, Cui W. Ultrasound technology and biomaterials for precise drug therapy. Materials Today 2023. [DOI: 10.1016/j.mattod.2022.12.004] [Reference Citation Analysis]
9 Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv 2022;29:2130-61. [PMID: 35815678 DOI: 10.1080/10717544.2022.2094498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mir SA, Hamid L, Bader GN, Shoaib A, Rahamathulla M, Alshahrani MY, Alam P, Shakeel F. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review. Molecules 2022;27:6608. [PMID: 36235145 DOI: 10.3390/molecules27196608] [Reference Citation Analysis]
11 Kalave S, Hegde N, Juvale K. Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer. Curr Pharm Des 2022;28:3140-57. [PMID: 35366765 DOI: 10.2174/1381612828666220401142300] [Reference Citation Analysis]
12 Constantinescu T, Mihis AG. Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones. Int J Mol Sci 2022;23:11595. [PMID: 36232899 DOI: 10.3390/ijms231911595] [Reference Citation Analysis]
13 Majchrzak-celińska A, Sidhu A, Miechowicz I, Nowak W, Barciszewska A. ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors. JCM 2022;11:5655. [DOI: 10.3390/jcm11195655] [Reference Citation Analysis]
14 Yadav P, Ambudkar SV, Rajendra Prasad N. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01626-z] [Reference Citation Analysis]
15 Targhazeh N, Hutt KJ, Winship AL, Reiter R, Yousefi B. Melatonin as an oncostatic agent: Review of the modulation of tumor microenvironment and overcoming multidrug resistance. Biochimie 2022:S0300-9084(22)00244-9. [PMID: 36116742 DOI: 10.1016/j.biochi.2022.09.010] [Reference Citation Analysis]
16 Sancha SAR, Gomes AV, Loureiro JB, Saraiva L, Ferreira MU. Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells. Molecules 2022;27:5759. [DOI: 10.3390/molecules27185759] [Reference Citation Analysis]
17 Rout SK, Priya V, Setia A, Mehata AK, Mohan S, Albratty M, Najmi A, Meraya AM, Makeen HA, Tambuwala MM, Muthu MS. Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy. Biomedicine & Pharmacotherapy 2022;153:113451. [DOI: 10.1016/j.biopha.2022.113451] [Reference Citation Analysis]
18 Słomka A, Wang B, Mocan T, Horhat A, Willms AG, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA, Lukacs-Kornek V, Kornek MT. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts? Theranostics 2022;12:5836-55. [PMID: 35966579 DOI: 10.7150/thno.73400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sokol MB, Yabbarov NG, Mollaeva MR, Chirkina MV, Mollaev MD, Zabolotsky AI, Kuznetsov SL, Nikolskaya ED. Alpha-fetoprotein mediated targeting of polymeric nanoparticles to treat solid tumors. Nanomedicine (Lond) 2022;17:1217-35. [PMID: 36136593 DOI: 10.2217/nnm-2022-0097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mohi-Ud-Din R, Mir RH, Mir PA, Banday N, Shah AJ, Sawhney G, Bhat MM, Batiha GE, Pottoo FH. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery. Curr Drug Metab 2022;23:735-56. [PMID: 35980054 DOI: 10.2174/1389200223666220817115003] [Reference Citation Analysis]
21 Vaghari-Tabari M, Hassanpour P, Sadeghsoltani F, Malakoti F, Alemi F, Qujeq D, Asemi Z, Yousefi B. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. Cell Mol Biol Lett 2022;27:49. [PMID: 35715750 DOI: 10.1186/s11658-022-00348-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bukowski K, Marciniak B, Kciuk M, Mojzych M, Kontek R. Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro. Molecules 2022;27:3761. [PMID: 35744887 DOI: 10.3390/molecules27123761] [Reference Citation Analysis]
23 Wang D, Liu M, Wu Y, Weng T, Wang L, Zhang Y, Zhao Y, Han J. Idarubicin/mithramycin-acridine orange combination drugs co-loaded by DNA nanostructures: Different effects of intercalation and groove binding on drug release and cytotoxicity. Journal of Molecular Liquids 2022;355:118947. [DOI: 10.1016/j.molliq.2022.118947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang Q, Hou D, Wen X, Xin M, Li Z, Wu L, Pathak JL. Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects. Mater Today Bio 2022;15:100333. [PMID: 35774196 DOI: 10.1016/j.mtbio.2022.100333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Aguda O, Lateef A. Recent advances in functionalization of nanotextiles: A strategy to combat harmful microorganisms and emerging pathogens in the 21st century. Heliyon 2022;8:e09761. [DOI: 10.1016/j.heliyon.2022.e09761] [Reference Citation Analysis]
26 Raj W, Jerczynski K, Rahimi M, Pavlova E, Šlouf M, Przekora A, Pietrasik J. Stimuli-responsive vitamin E-based micelles: Effective drug carriers with a controlled anticancer drug release. Polymer 2022;253:125001. [DOI: 10.1016/j.polymer.2022.125001] [Reference Citation Analysis]
27 Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Mondal B, Kundu MK, Dey A, Rahman MH, Antonescu A, Cavalu S. Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells. Life 2022;12:811. [DOI: 10.3390/life12060811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Ahmed T, Liu FF, Lu B, Lip H, Park E, Alradwan I, Liu JF, He C, Zetrini A, Zhang T, Ghavaminejad A, Rauth AM, Henderson JT, Wu XY. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs. Mol Pharm 2022. [PMID: 35587783 DOI: 10.1021/acs.molpharmaceut.2c00038] [Reference Citation Analysis]
29 Majerník M, Jendželovský R, Vargová J, Jendželovská Z, Fedoročko P. Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer. Pharmaceutics 2022;14:1075. [DOI: 10.3390/pharmaceutics14051075] [Reference Citation Analysis]
30 Goh KS, Ng ZJ, Halim M, Oslan SN, Oslan SNH, Tan JS. A Comprehensive Review on the Anticancer Potential of Bacteriocin: Preclinical and Clinical Studies. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10386-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Banthia P, Gambhir L, Sharma A, Daga D, Kapoor N, Chaudhary R, Sharma G. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 2022;12:70. [PMID: 35223356 DOI: 10.1007/s13205-022-03121-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kara G. siRNA targeting ABCB1 potentiates the efficacy of chemotherapy in human triple-negative breast cancer cells. HJBC 2022. [DOI: 10.15671/hjbc.975466] [Reference Citation Analysis]
33 Mirza-aghazadeh-attari M, Mihanfar A, Yousefi B, Majidinia M. Nanotechnology-based advances in the efficient delivery of melatonin. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02472-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Saha P, Bose S, Javed MN, Srivastava AK. Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery. Advances in Nanotechnology-Based Drug Delivery Systems 2022. [DOI: 10.1016/b978-0-323-88450-1.00024-7] [Reference Citation Analysis]
35 Jančič U, Gorgieva S. Bromelain and Nisin: The Natural Antimicrobials with High Potential in Biomedicine. Pharmaceutics 2021;14:76. [PMID: 35056972 DOI: 10.3390/pharmaceutics14010076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
36 Wang W, Zhou M, Xu Y, Peng W, Zhang S, Li R, Zhang H, Zhang H, Cheng S, Wang Y, Wei X, Yue C, Yang Q, Chen C. Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer: In Vivo and In Vitro Study. Front Bioeng Biotechnol 2021;9:762489. [PMID: 34950642 DOI: 10.3389/fbioe.2021.762489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kraus S, Khandadash R, Hof R, Nyska A, Sigalov E, Eltanani M, Rukenstein P, Rabinovitz R, Kassem R, Antebi A, Shalev O, Cohen-Erner M, Goss G, Cyjon A. Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model. Front Oncol 2021;11:761045. [PMID: 34804962 DOI: 10.3389/fonc.2021.761045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Molaparast M, Ehsanimehr S, Kahyaei M, Mahboubi N, Shafiei-irannejad V. Polymeric complex based on poly (styrene-alt-maleic anhydride)- targeted with folic acid for doxorubicin delivery to HT-29 colorectal cancer cells. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2021.1999953] [Reference Citation Analysis]
39 Zhang C, Liu H, Gong M, Yang M, Yang Z, Xie Y, Cai L. Biomimetic gold nanocages for overcoming chemoresistance of osteosarcoma by ferroptosis and immunogenic cell death. Materials & Design 2021;210:110087. [DOI: 10.1016/j.matdes.2021.110087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
40 McFadden M, Singh SK, Oprea-Ilies G, Singh R. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers (Basel) 2021;13:5480. [PMID: 34771642 DOI: 10.3390/cancers13215480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Raj W, Jerczynski K, Rahimi M, Przekora A, Matyjaszewski K, Pietrasik J. Molecular bottlebrush with pH-responsive cleavable bonds as a unimolecular vehicle for anticancer drug delivery. Mater Sci Eng C Mater Biol Appl 2021;130:112439. [PMID: 34702524 DOI: 10.1016/j.msec.2021.112439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
42 Manisekaran R, García-Contreras R, Rasu Chettiar AD, Serrano-Díaz P, Lopez-Ayuso CA, Arenas-Arrocena MC, Hernández-Padrón G, López-Marín LM, Acosta-Torres LS. 2D Nanosheets-A New Class of Therapeutic Formulations against Cancer. Pharmaceutics 2021;13:1803. [PMID: 34834218 DOI: 10.3390/pharmaceutics13111803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines 2021;9:1353. [PMID: 34680470 DOI: 10.3390/biomedicines9101353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
44 Gunaydin G, Gedik ME, Ayan S. Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status. Front Chem 2021;9:686303. [PMID: 34409014 DOI: 10.3389/fchem.2021.686303] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 23.5] [Reference Citation Analysis]
45 Liang Y, Liu ZY, Wang PY, Li YJ, Wang RR, Xie SY. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. J Control Release 2021;336:396-409. [PMID: 34175367 DOI: 10.1016/j.jconrel.2021.06.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
46 Demircan Yalçın Y, Töral TB, Sukas S, Yıldırım E, Zorlu Ö, Gündüz U, Külah H. A microfluidic device enabling drug resistance analysis of leukemia cells via coupled dielectrophoretic detection and impedimetric counting. Sci Rep 2021;11:13193. [PMID: 34162990 DOI: 10.1038/s41598-021-92647-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Hasan-nasab B, Ebrahimnejad P, Ebrahimi P, Sharifi F, Salili M, Shahlaee F, Nokhodchi A. A promising targeting system to enrich irinotecan antitumor efficacy: Folic acid targeted nanoparticles. Journal of Drug Delivery Science and Technology 2021;63:102543. [DOI: 10.1016/j.jddst.2021.102543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Li D, Gao C, Kuang M, Xu M, Wang B, Luo Y, Teng L, Xie J. Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy. Molecules 2021;26:2380. [PMID: 33921892 DOI: 10.3390/molecules26082380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
49 Bessone F, Dianzani C, Argenziano M, Cangemi L, Spagnolo R, Maione F, Giraudo E, Cavalli R. Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance. Cancer Drug Resist 2021;4:192-207. [PMID: 35582009 DOI: 10.20517/cdr.2020.65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Awad NS, Paul V, AlSawaftah NM, Ter Haar G, Allen TM, Pitt WG, Husseini GA. Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review. ACS Pharmacol Transl Sci 2021;4:589-612. [PMID: 33860189 DOI: 10.1021/acsptsci.0c00212] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
51 Gajda E, Grzanka M, Godlewska M, Gawel D. The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance. Pharmaceuticals (Basel) 2021;14:149. [PMID: 33673265 DOI: 10.3390/ph14020149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
52 Winum J. Nanostructures and innovative delivery systems for overcoming cancer resistance. pH-Interfering Agents as Chemosensitizers in Cancer Therapy 2021. [DOI: 10.1016/b978-0-12-820701-7.00002-6] [Reference Citation Analysis]
53 Natesan S, Vellayutham R, Krishnaswami V, Ponnusamy C, Thekkilaveedu S, Pathayappurakkal Mohanan D, Kandasamy R. Enhanced Topical Delivery of Drugs to the Eye Using Chitosan Based Systems. Advances in Polymer Science 2021. [DOI: 10.1007/12_2021_105] [Reference Citation Analysis]
54 Narayan S. Challenges and Future Opportunities of Nanomedicine in Cancer Therapy. Nanomedicine for Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-981-15-7564-8_10] [Reference Citation Analysis]
55 Nakonieczna S, Grabarska A, Kukula-Koch W. The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer-A Review on In Vitro, In Vivo, and Clinical Studies. Int J Mol Sci 2020;21:E8307. [PMID: 33167519 DOI: 10.3390/ijms21218307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
56 Çağlayan Z, Demircan Yalçın Y, Külah H. A Prominent Cell Manipulation Technique in BioMEMS: Dielectrophoresis. Micromachines (Basel) 2020;11:E990. [PMID: 33153069 DOI: 10.3390/mi11110990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
57 Skotadis E, Aslanidis E, Kainourgiaki M, Tsoukalas D. Nanoparticles Synthesised in the Gas-Phase and Their Applications in Sensors: A Review. Applied Nano 2020;1:70-86. [DOI: 10.3390/applnano1010006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
58 Kreutzer D, Ritter CA, Hilgeroth A. Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy. Pharmaceuticals (Basel) 2020;13:E146. [PMID: 32660005 DOI: 10.3390/ph13070146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, Xanthopoulou E, Bikiaris DN. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers (Basel) 2020;12:E1519. [PMID: 32650536 DOI: 10.3390/polym12071519] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
60 Verkoyen P, Frey H. Long‐Chain Alkyl Epoxides and Glycidyl Ethers: An Underrated Class of Monomers. Macromol Rapid Commun 2020;41:2000225. [DOI: 10.1002/marc.202000225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Bilal M, Xu C, Cao L, Zhao P, Cao C, Li F, Huang Q. Indoxacarb‐loaded fluorescent mesoporous silica nanoparticles for effective control of Plutella xylostella L. with decreased detoxification enzymes activities. Pest Manag Sci 2020;76:3749-58. [DOI: 10.1002/ps.5924] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
62 Deda DK, Iglesias BA, Alves E, Araki K, Garcia CRS. Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents. Molecules 2020;25:E2080. [PMID: 32365664 DOI: 10.3390/molecules25092080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
63 Mello FVC, de Moraes GN, Maia RC, Kyeremateng J, Iram SH, Santos-Oliveira R. The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein. Int J Mol Sci 2020;21:E2630. [PMID: 32290047 DOI: 10.3390/ijms21072630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]